(Q34254760)

31 July 2017

1 reference

title

Efficacy, pharmacology, and adverse effects of antiepileptic drugs (English)

1 reference

31 July 2017

1 reference

Holland KD

1

1 reference

31 July 2017

publication date

1 May 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

19

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

313-345

1 reference

Pharmacokinetics of fosphenytoin in patients with hepatic or renal disease

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Oxcarbazepine: pharmacokinetic interactions and their clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Cross-reactive skin eruption with both carbamazepine and oxcarbazepine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Comparative pharmacokinetics of the newer antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Drug interaction profile of topiramate

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Pharmacology and pharmacokinetics of fosphenytoin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Methsuximide for complex partial seizures: efficacy, toxicity, clinical pharmacology, and drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Zonisamide-induced mania

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Multiorgan dysfunction and disseminated intravascular coagulation in children receiving lamotrigine and valproic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Characterization of ethosuximide reduction of low-threshold calcium current in thalamic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Changes in body weight with chronic, high-dose gabapentin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Felbamate in the treatment of Lennox-Gastaut syndrome: results of a 12-month open-label study following a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Valproic acid hepatic fatalities: a retrospective review

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Pharmacokinetic Interactions Between Lamotrigine and Other Antiepileptic Drugs in Children with Intractable Epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Metabolic characteristics of oxcarbazepine (®trileptal) and their beneficial implications for enzyme induction and drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Phenobarbital for febrile seizures--effects on intelligence and on seizure recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Efficacy of felbamate in childhood epileptic encephalopathy (Lennox-Gastaut syndrome).

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Treatment issues for women with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Oxcarbazepine in the treatment of early childhood epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Lamotrigine: pharmacokinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

1 reference

7 January 2021

Long-term response to topiramate in patients with West syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Topiramate in Lennox-Gastaut syndrome: open-label treatment of patients completing a randomized controlled trial. Topiramate YL Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

A single-dose study to define tiagabine pharmacokinetics in pediatric patients with complex partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Neuropharmacology of zonisamide, a new antiepileptic drug

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

1 reference

7 January 2021

Population analysis of the dose-dependent pharmacokinetics of zonisamide in epileptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Progressive myoclonus epilepsy treated with zonisamide

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Felbamate for refractory infantile spasms

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Oxcarbazepine (GP 47.680): a possible alternative to carbamazepine?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Hyponatremia induced by oxcarbazepine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Photosensitive epilepsy: a model to study the effects of antiepileptic drugs. Evaluation of the piracetam analogue, levetiracetam

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Evaluation of case reports of aplastic anemia among patients treated with felbamate

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Valproic acid selectively reduces the low-threshold (T) calcium current in rat nodose neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Zonisamide-induced behavior disorder in two children.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Possible interaction between oxcarbazepine and an oral contraceptive

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Tiagabine-induced absence status in idiopathic generalized epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

1 reference

7 January 2021

Safety of tiagabine: summary of 53 trials

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Efficacy and safety of zonisamide: results of a multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

New antiepileptic drugs: a systematic review of their efficacy and tolerability

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

1 reference

7 January 2021

Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

1 reference

7 January 2021

Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Oxcarbazepine-induced hyponatremia, a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Felbamate-associated fatal acute hepatic necrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Newer antiepileptic drugs. Towards an improved risk-benefit ratio

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Carbamazepine side effects in children and adults

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

1 reference

7 January 2021

Hyponatraemia during oxcarbazepine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

The clinical pharmacokinetics of the newer antiepileptic drugs. Focus on topiramate, zonisamide and tiagabine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Safety of lamotrigine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Topiramate: a review of preclinical, pharmacokinetic, and clinical data

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

A study of topiramate pharmacokinetics and tolerability in children with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Tiagabine therapy for complex partial seizures. A dose-frequency study. The Tiagabine Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Pilot study of zonisamide (1,2-benzisoxazole-3-methanesulfonamide) in patients with refractory partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

1 reference

7 January 2021

Oxcarbazepine: Double-blind, randomized, placebo-control, monotherapy trial for partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Lamotrigine-associated anticonvulsant hypersensitivity syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Phenytoin and carbamazepine: potential- and frequency-dependent block of Na currents in mammalian myelinated nerve fibers

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Efficacy and tolerability study of ucb L059 in patients with refractory epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Heat stroke-like episode in a child caused by zonisamide

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Treatment of status epilepticus

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

The pharmacokinetics of tiagabine in healthy elderly volunteers and elderly patients with epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Tiagabine, a novel antiepileptic agent: lack of pharmacokinetic interaction with digoxin.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Zonisamide monotherapy in newly diagnosed infantile spasms

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

A summary of mechanistic hypotheses of gabapentin pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

1 reference

7 January 2021

Differential regulation of gamma-aminobutyric acid receptor channels by diazepam and phenobarbital

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

The long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in drug-resistant partial epilepsy. The US Gabapentin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Tiagabine for complex partial seizures: a randomized, add-on, dose-response trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Nonlinear pharmacokinetics of CI-912 in adult epileptic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Interaction of Felbamate with [3H]DCKA-Labeled Strychnine-Insensitive Glycine Receptors in Human Postmortem Brain

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Zonisamide in epilepsy: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

New formulations of drugs in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Treatment of infantile spasms with zonisamide

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970021-9

7 January 2021

10.1016/S0733-8619(05)70021-9

Identifiers

DOI

1 reference

31 July 2017

1 reference